Luciferase Reporter Gene Assay Kit |
Z5030001 |
Biochain |
200 assays |
EUR 329 |
Human IgG antibody Laboratories manufactures the dual luciferase reporter gene assay reagents distributed by Genprice. The Dual Luciferase Reporter Gene Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Dual products are available in stock. Specificity: Dual Category: Luciferase Group: Reporter Gene
Luciferase Reporter Assay Kit |
ApexBio |
200 assays |
EUR 204.8 |
Description: Tools Kit|Molecular Biology Kit#Kits|Tools Kit#Kits |
Luciferase Reporter Assay Kit |
Biovision |
each |
EUR 235.2 |
Single-Luciferase Reporter Assay Kit |
Abbexa |
100 µl |
EUR 650 |
Single-Luciferase Reporter Assay Kit |
Abbexa |
1 ml |
Ask for price |
Single-Luciferase Reporter Assay Kit |
Abbexa |
200 µl |
EUR 762.5 |
Single-Luciferase Reporter Assay Kit |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Double-Luciferase Reporter Assay Kit |
Abbexa |
100 µl |
EUR 687.5 |
Reporter Gene information
Luciferase Reporter Assay Kit |
K2181-200 |
ApexBio |
200 assays |
EUR 204.8 |
Description: Tools Kit|Molecular Biology Kit#Kits|Tools Kit#Kits |
Luciferase Reporter Assay Kit |
K801-200 |
Biovision |
each |
EUR 235.2 |
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Maximized Luminescence* |
12536 |
AAT Bioquest |
10 plates |
EUR 1092 |
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
ADAR1 Dual Luciferase Reporter HEK293 Cell Line |
78547 |
BPS Bioscience |
2 vials |
EUR 19950 |
Description: The ADAR1 Luciferase Reporter HEK293 cell line is designed to monitor RNA editing by Adenosine deaminase acting on RNA (ADAR1). This cell line stably expresses ADAR1 under the control of a CMV promoter and a separate ADAR editing reporter construct expressed under the control of another CMV promoter. The reporter contains the gene encoding firefly luciferase, which is constitutively expressed in the cells, upstream of the gene encoding the GluA2 ADAR substrate followed by the Renilla luciferase gene. The sequence corresponding to GluA2 has been modified to contain an amber stop codon (UAG). When edited by ADAR, this stop codon (UAG) will be changed to UIG (A to I edit), which is read as tryptophan (UGG) by the translation machinery. This edit allows translation to occur all the way to the end of the reporter mRNA and results in the expression of Renilla luciferase. Conversely, in the absence of ADAR1 activity, translation terminates at the stop codon and Renilla is not expressed. Reporter activity is read out as the Renilla Luciferase/Firefly luciferase ratio whereby inhibition of ADAR activity, and thus the UAG (stop) to UGG (tryptophan) conversion rate, will result in a dose-dependent decrease in the Renilla luciferase/Firefly luciferase ratio. |
SuperLight Dual Luciferase Repo0er Gene Assay Kit |
SLDL-100 |
BioAssay Systems |
100 |
EUR 199 |
SRE Luciferase Reporter Lentivirus |
78627 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The SRE (Serum Response Element) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Serum Response Element located upstream of the minimal TATA promoter . After transduction, activation of the MAPK/ERK signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Myc Luciferase Reporter Lentivirus |
78628 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The Myc Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Myc response element located upstream of the minimal TATA promoter and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the Myc signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
p53 Luciferase Reporter Lentivirus |
78666 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The p53 Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by p53 response elements located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, p53-regulated gene expression in the target cells can be monitored by measuring the luciferase activity. |
HRE Luciferase Reporter Lentivirus |
78668 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The Hypoxia Response Element (HRE) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by four copies of a hypoxia response elements (HRE) located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the induction of hypoxia in the target cells can be monitored by measuring the luciferase activity. |
ARE Luciferase Reporter Lentivirus |
79869 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Nrf2 antioxidant response pathway plays an important role in the cellular antioxidant defense. Nrf2, a basic leucine zipper transcription factor, induces the expression of antioxidant and phase II enzymes by binding to the ARE (antioxidant response element) region of the gene promoter. Under basal conditions, Nrf2 is retained in the cytosol by binding to the cytoskeletal protein Keap1. Upon exposure to oxidative stress or other ARE activators, Nrf2 is released from Keap1 and translocates to the nucleus, where it can bind to the ARE, leading to the expression of antioxidant and phase II enzymes that protect the cell from oxidative damage. The ARE Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by ARE located upstream of the minimal TATA promoter. After transduction, activation of the Nrf2 antioxidant response pathway in the target cells can be monitored by measuring the luciferase activity. |
TEAD Luciferase Reporter Lentivirus |
79833 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Hippo pathway regulates cell proliferation and cell death. It is activated by high cell density and cell stress to stop cell proliferation and induce apoptosis. The mammalian Hippo pathway comprises MST kinases and LATS kinases. When the Hippo pathway is activated, MST kinases phosphorylate LATS kinases, which phosphorylate transcriptional co-activators YAP and TAZ. Unphosphorylated YAP and TAZ remain in nucleus and interact with TEAD/TEF transcriptional factors to turn on cell cycle-promoting gene transcription. However, when phosphorylated, YAP and TAZ are recruited from the nucleus to the cytosol, so that the YAP and TAZ-dependent gene transcription is turned off. Dysfunction of the Hippo pathway is frequently detected in human cancer and its down-regulation correlates with the aggressive properties of cancer cells and poor prognosis. The TEAD Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the TEAD response elements located upstream of the minimal TATA promoter. After transduction, activation of the Hippo pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT3 Luciferase Reporter Lentivirus |
79744 |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The STAT3 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT3-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT3 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT5 Luciferase Reporter Lentivirus |
79745 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The STAT5 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT5-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT5 signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
T24 Luciferase Reporter Cell Line |
ABC-RC123H |
AcceGen |
each |
Ask for price |
|
4T1 Luciferase Reporter Cell Line |
ABC-RC286H |
AcceGen |
each |
Ask for price |
|
T84 Luciferase Reporter Cell Line |
ABC-RC724H |
AcceGen |
each |
Ask for price |
|
SCC7 Luciferase Reporter Cell Line |
ABC-RC135H |
AcceGen |
each |
Ask for price |
|